|
Symbol
|
LVBVLK | XRYLTQ | IHTEFG | LCDQLK | LTHCLK | OOJRCH | AAIDTQ | 1016BC | POMRCH | PRZRCH | PWCRCH | RMAA0V | RMBX0V | RMATBV | RMAZDV | LZMRCH | LZORCH | RMBJ7V | MAIRCH | RCDRCH |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | LUKB Autocallable Multi Reverse Convertible | Multi Reverse Convertible | Reverse Convertible | LUKB Multi Reverse Convertible | LUKB Softcallable Multi Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Reverse Convertible | Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Autocallable Reverse Convertible | Multi Vonti | Multi Vonti | Multi Vonti | Multi Vonti | Worst of Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Autocallable Reverse Convertible |
|
Sous-jacent
|
Nestlé S.A. / Swatch Group I / Swiss Life Hldg. N / Swiss RE AG | Compagnie Financière Richemont SA / Novartis Sandoz Basket / Roche PS / Swatch Group I / Swiss RE AG | Compagnie Financière Richemont SA / Lonza Group N / Sonova Hldg. AG / Swiss RE AG / Swisscom N | Partners Group Hldg. AG / Swiss Life Hldg. N / Swiss RE AG | ABB / Nestlé S.A. / Novartis AG / Roche PS / Swiss RE AG | Barry Callebaut AG / Nestlé S.A. / Roche PS / Swiss RE AG / UBS Group AG | Swiss Life / Swiss Re / Zurich | Nestlé S.A. / Sika AG / Swiss RE AG | Swiss Re / UBS / Zurich | Lonza Group N / Swiss Life Hldg. N / Swiss RE AG | Kühne & Nagel Intl. AG / Logitech International SA / Lonza Group N / Swiss RE AG / UBS Group AG | Swiss Life Hldg. N / Swiss RE AG / Zurich Insurance Group AG / Helvetia Baloise Holding AG | Schindler PS / Swiss RE AG / Swisscom N | Companie Financière Richemont SA / Geberit AG / Swiss RE AG | Nestlé S.A. / Partners Group Hldg. AG / Swiss RE AG | Holcim AG / Swiss RE AG / Lonza Group N | Swiss Life Hldg. N / Swiss RE AG / Helvetia Baloise Holding AG | Sika AG / Swiss RE AG / UBS Group AG / Zurich Insurance Group AG | Swiss Life / Swiss Re / Zurich | Novartis AG / Roche PS / Swiss Life Hldg. N / Swiss RE AG / Zurich Insurance Group AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
20.07.2026 | 22.09.2028 | 28.06.2029 | 03.06.2026 | 09.07.2027 | 15.07.2026 | 19.07.2027 | 06.11.2026 | 31.07.2026 | 24.02.2027 | 27.06.2029 | 26.04.2027 | 31.05.2027 | 25.06.2026 | 09.07.2026 | 31.07.2026 | 07.08.2029 | 19.08.2027 | 24.09.2027 | 26.09.2028 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
68,952 | 160,62 | 176,28 | 824,8414 | 58,7776 | 997,10 | 60,94 | 158,665 | 103,5375 | 416,78 | 364,13 | 113,44 | 103,04 | 407,30 | 791,945 | 110,6625 | 110,5875 | 142,30 | 103,9125 | 97,685 |
| rendement max. p.a. | 18,98% | 8,97% | - | 12,35% | 5,88% | 4,52% | 1,90% | 34,26% | 1,37% | 6,91% | 7,94% | 7,94% | 6,72% | 0,98% | 11,89% | 5,69% | 6,23% | 15,76% | 6,08% | 5,40% |
| Demande | 97,50 | 89,68 | 88,21 | - | 98,52 | 99,77 | 101,09 | 94,64 | 99,99 | 97,71 | 90,53 | 96,40 | 97,10 | 100,10 | 98,40 | 98,36 | 94,03 | 88,20 | 98,04 | 99,00 |
| Offre | 98,23 | 90,48 | - | - | 99,27 | 100,57 | 101,90 | 95,39 | 100,79 | 98,51 | 91,33 | 97,40 | 98,10 | 101,10 | 99,40 | 99,16 | 94,83 | 89,20 | 98,84 | 99,80 |